Pacira BioSciences, Inc. (PCRX)

NASDAQ: PCRX · Real-Time Price · USD

23.15

-0.49 (-2.07%)

May 8, 2026, 4:00 PM EDT - Market closed

Pacira BioSciences Balance Sheet

Financials in millions USD. Fiscal year is January - December.

Millions USD. Fiscal year is Jan - Dec.

Fiscal Year	TTM	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Mar '26 Mar 31, 2026	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Cash & Equivalents	144.31	158.55	276.77	153.3	104.14	585.58
Cash & Short-Term Investments	144.31	158.55	276.77	153.3	104.14	585.58
Cash Growth	-49.12%	-42.72%	80.55%	47.21%	-82.22%	485.83%
Total Current Assets	144.31	158.55	276.77	153.3	104.14	585.58
Total Assets	144.31	158.55	276.77	153.3	104.14	585.58
Long-Term Debt	367.66	372.19	-	-	-	-
Total Long-Term Liabilities	367.66	372.19	-	-	-	-
Total Liabilities	367.66	372.19	-	-	-	-
Total Liabilities & Equity	367.66	372.19	-	-	-	-
Total Debt	367.66	372.19	0	0	0	0
Net Cash (Debt)	-223.35	-213.64	276.77	153.3	104.14	585.58
Net Cash Growth	-	-	80.55%	47.21%	-82.22%	485.83%
Net Cash Per Share	-5.14	-4.74	5.99	2.95	2.24	12.83

Updated Apr 30, 2026. Data Source: Fiscal.ai. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q